The acquisition by Kiara Health of a multinational pharmaceutical manufacturing facility, sold to fulfil a need for transformation in the local pharmaceutical sector, sees the dawn of a new type of pharmaceutical company that offers an end-to-end solution along the patient journey.
Pan-African pharmaceutical company, Kiara Health, has kicked off its Industry 4.0 journey, partnering with Datacentrix, a high performing and secure ICT solutions provider.
Cardiac arrhythmias are very common but underdiagnosed due to their transient and asymptomatic nature.
Effective August 2020, Imperial acquired a 49% shareholding in Pharmafrique (Pty) Ltd (trading as Kiara Health).
Tuesday, 3 July 2018 Young pan-African pharmaceutical company, Kiara Health, has been awarded the coveted Africa Visionary Innovation